Here, we discovered from the gene-drug interaction network that testosterone resulted in decreased expression of HMGB2, while estradiol and progesterone gave rise to up-regulation of PDGFRA, which is in accordance with the expression of HMGB2 and PDGFRA in PCOS. Here, HMGB2 is linked to polycystic ovary syndrome.